Xenon Pharmaceuticals Inc. XENE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-10-17
Xenon Pharmaceuticals Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 2,886,390 | $167.8M |
| BlackRock Finance, Inc. | 2,095,894 | $81.7M |
| TWO SIGMA INVESTMENTS, LP | 606,085 | $35.2M |
| RENAISSANCE TECHNOLOGIES LLC | 300,500 | $17.5M |
| MILLENNIUM MANAGEMENT LLC | 201,785 | $11.7M |
| D. E. Shaw & Co., Inc. | 38,740 | $2.3M |
| Point72 Asset Management, L.P. | 18,600 | $1.1M |
| AQR CAPITAL MANAGEMENT LLC | 7,279 | $423,274 |
Source: SEC EDGAR filings · CIK 0001582313 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.